ACTR-47. PHASE-III TRIAL OF STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135)

Stupp treatment protocol for patients with glioblastoma (GBM) has improved the median overall survival to 14.6 months. However, no investigations have defined effective strategies against recurrence and the prognosis of recurrent GBM patients remains poor. Personalized medicine with assay-guided tre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Ranjan, Tulika, Aregawi, Dawit, Lu-Emerson, Christine, Schroeder, Jason, Anderson, Mark, Chaudhary, Rekha
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Adult Clinical Trials - Non-Immunologic
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847312/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.089
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi